Format

Send to

Choose Destination
Anticancer Res. 1989 Mar-Apr;9(2):391-3.

Intrapleural BCG in postsurgical stage I non-small cell lung cancer.

Author information

1
Service of Thoracic Surgery, University of Pisa, Italy.

Abstract

In a randomized trial comparing intrapleural bacillus Calmette-Guérin (BCG) with placebo in postsurgical stage I non-small cell lung cancer, BCG-treated patients (n = 17) showed a non-significant overall improvement of 5-year and median survival and disease-free interval, but an increased rate of recurrence of cancer compared with control patients (n = 17).

PMID:
2546484
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center